Bausch Health Companies Inc (BHC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 208,389 | 154,936 | 122,276 | 127,002 | 131,885 |
| Income taxes - deferred | -138,736 | -72,259 | -18,724 | -19,773 | -119,903 |
| Accounts receivable | -70,749 | -43,087 | 67,736 | -118,481 | 3,559 |
| Accounts payable and accrued liabilities | -15,479 | 16,808 | 27,497 | -37,806 | -68,081 |
| Other Working Capital | -65,135 | -17,573 | 32,426 | -86,837 | -102,315 |
| Other Operating Activity | 271,490 | 134,882 | -4,555 | 222,225 | 153,456 |
| Operating Cash Flow | $189,780 | $173,707 | $226,656 | $86,330 | $-1,399 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,952 | -9,584 | -12,474 | -21,505 | -9,210 |
| Net Acquisitions | -1,494,785 | -409,056 | -96,565 | -463,702 | -84,532 |
| Purchase Of Investment | 0 | -11,745 | -29,326 | -40,016 | 0 |
| Sale Of Investment | 0 | 0 | 83,865 | 2,774 | 1,000 |
| Purchase Sale Intangibles | -4,315 | -12,237 | -8,000 | -302,885 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 59,546 |
| Investing Cash Flow | $-1,514,052 | $-442,622 | $-62,500 | $-825,334 | $-33,196 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,459,111 | 690,000 | 100,000 | 2,139,688 | 992,400 |
| Debt Repayment | -1,090,424 | -213,675 | -199,788 | -1,114,225 | -783,881 |
| Common Stock Repurchased | -65,122 | -74,556 | -224,814 | -274,750 | N/A |
| Dividend Paid | 0 | 0 | 0 | 0 | -312,725 |
| Other Financing Activity | -67,023 | -102,744 | -5,567 | -7,946 | -60,283 |
| Financing Cash Flow | $1,236,542 | $299,025 | $-330,169 | $742,767 | $-164,489 |
| Exchange Rate Effect | -2,718 | -14,496 | 3,206 | 3,720 | 699 |
| Beginning Cash Position | 254,559 | 238,945 | 401,752 | 394,269 | 592,654 |
| End Cash Position | 164,111 | 254,559 | 238,945 | 401,752 | 394,269 |
| Net Cash Flow | $-87,730 | $30,110 | $-166,013 | $3,763 | $-199,084 |
| Free Cash Flow | |||||
| Operating Cash Flow | 189,780 | 173,707 | 226,656 | 86,330 | -1,399 |
| Capital Expenditure | -19,267 | -21,821 | -20,474 | -324,390 | N/A |
| Free Cash Flow | 170,513 | 151,886 | 206,182 | -238,060 | -1,399 |